BIOSYNTIA ApS: Financial statements 2015
CVR: 34892970
Source: annual report 2015, Danish Business Authority
01/01/2015 – 31/12/2015
BIOSYNTIA ApS (CVR 34892970) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK 1,157,909 and a net result of DKK -1,682,434 compared with DKK -3,885 the year before. That is a decrease of 26.6% compared with the year before. Equity in the 2015 report amounted to DKK 3,865,904. The solvency ratio was 59.1%.
- Gross Profit
- DKK 1,157,909
- Profit/Loss
- DKK -1,682,434
- Equity
- DKK 3,865,904
- Total Assets
- DKK 6,541,664
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | - | 1.2 mio. | -1.7 mio. | 3.9 mio. | - |
| 2014 | - | 1.6 mio. | -4 t. | 48 t. | - |
| 2013 | - | 389 t. | -28 t. | 52 t. | - |
Official annual report
How creditworthy is BIOSYNTIA ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2015
As of May 7, 2015, Søren Knud Carlsen has joined the board of directors of BIOSYNTIA ApS.
As of May 7, 2015, Søren Møller has joined the board of directors of BIOSYNTIA ApS.
As of May 7, 2015, Hans Jasper Genee has left the board of directors of BIOSYNTIA ApS.
As of May 7, 2015, Morten Otto Alexander Sommer is registered as adm. dir. of BIOSYNTIA ApS.
As of May 7, 2015, Hans Jasper Genee has stepped down as adm. dir. of BIOSYNTIA ApS.
BIOSYNTIA ApS has published its annual report for 2014. Gross profit came to DKK 1,577,651, and the net result was DKK -3,885.
About BIOSYNTIA ApS
BIOSYNTIA ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2012. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Martin Plambech. The board consists of Henrik Dalbøge (chair), Joško Bobanović and Thomas Grotkjær. The company's owners include Novo Holdings A/S, Danmarks Eksport- og Investeringsfond and Sofinnova Industrial Biotech I. The company has 25 employees (2018). In 2025, the company reported a gross profit of DKK -14,222,601 and a net result of DKK -20,066,332 compared with DKK -18,909,140 the year before. Equity in the 2025 report amounted to DKK 32,860,576.